CRWD Form 144: Insider intends to sell 10,706 Class A shares (~$5.3M)
Rhea-AI Filing Summary
CrowdStrike Holdings insider sales are reported on a Form 144 for Class A common stock. The filing notifies intent to sell 10,706 shares with an aggregate market value of $5,306,617.33 on or about 09/22/2025 through Fidelity Brokerage Services on NASDAQ. The securities were acquired on 09/20/2025 by PSU and RSU vesting (5,819 and 4,887 shares respectively) and paid on 09/20/2025. The filer also disclosed three prior sales in the past three months totaling 38,597 shares that generated gross proceeds of $17,083,558.27 across sales on 05/05/2025, 06/23/2025, and 08/05/2025. The notice includes the standard signature representation that no undisclosed material adverse information is known.
Positive
- Disclosure compliance: The filer provides required details including acquisition dates, sale amount, broker, and aggregate market value.
- Vesting origin: The shares to be sold were acquired through PSU and RSU vesting on 09/20/2025, indicating they are routine compensation-related holdings.
Negative
- Insider liquidity: The filer has recently sold material amounts—38,597 shares in the last three months for total gross proceeds of $17,083,558.27, which may signal continued insider selling activity.
- No trading-plan disclosure: The filing does not specify adoption of a 10b5-1 trading plan or its date, so sales appear as standard notice rather than explicitly pre-planned trades.
Insights
TL;DR Insider intends to sell newly vested shares worth about $5.3M; recent months show substantial liquidity events.
The filing documents the planned sale of 10,706 Class A shares with an aggregate market value of $5,306,617.33 via Fidelity on NASDAQ, stemming from PSU and RSU vesting on 09/20/2025. The three prior reported sales in the last three months total 38,597 shares for $17,083,558.27 in gross proceeds. From a market-impact perspective, the single planned transaction is modest relative to total shares outstanding reported in the form (250,955,140), representing roughly 0.0043% of outstanding shares, so direct dilution or supply shock is limited. This is a routine disclosure of insider liquidity rather than an operational indicator.
TL;DR Filing appears procedurally compliant; disclosures show vesting-related sales and routine certifications.
The Form 144 provides required details about acquisition dates (09/20/2025), nature of acquisition (PSU and RSU vesting), and prior sales, and includes the declaration that the filer is unaware of undisclosed material adverse information. These elements align with Rule 144 procedural expectations. The filing does not state any trading plan adoption date or 10b5-1 plan specifics, so no affirmative indication of a pre-established trading schedule is present in the form text.